Non-invasive estimation of myocardial efficiency using positron emission tomography and carbon-11 acetate - Comparison between the normal and failing human heart

European Journal of Nuclear Medicine

Volumn 27, Issue 3, 2000, Pages 319-326

  Bengel, Frank M ^a,b   Permanetter, Bernhard ^c   Ungerer, Martin ^a   Nekolla, Stephan ^a   Schwaiger, Markus ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c NONE

Author keywords

Cardiac efficiency; Heart failure; Oxidative metabolism; Positron emission tomography

Indexed keywords

ACETIC ACID; CARBON 11;

ADULT; AEROBIC METABOLISM; ARTICLE; CLINICAL ARTICLE; FEMALE; HEART AFTERLOAD; HEART FAILURE; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART PERFORMANCE; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OXYGEN CONSUMPTION; POSITRON EMISSION TOMOGRAPHY; RADIOISOTOPE VENTRICULOGRAPHY;

EID: 0034107026     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002590050040     Document Type: Article

References (33)

1. Evans C, Matsuoka Y. The effect of various mechanical conditions on the gaseous metabolism and efficiency of the mammalian heart. J Physiol (Lond) 1919; 49: 378-405.
2. Bing R, Hammond M, Handelsman J, et al. The measurement of coronary blood flow, oxygen consumption, and efficiency of the left ventricle in man. Am Heart J 1949; 38: 1-24.
3. Franciosa J, Park M, Levine T. Lack of correlation between exercise capacity and indexes of left ventricular performance in heart failure. Am J Cardiol 1981; 47: 33-39.
4. Packer M. How should we judge the efficacy of drug therapy in patients with chronic congestive heart failure? The insights of six blind men. J Am Coll Cardiol 1987; 9: 433-438.
5. Baxley W, Dodge H, Rackley C, Sandier H, Pugh D. Left ventricular mechanical efficiency in man with heart disease. Circulation 1977; 55: 564-568.
6. Eichhorn EJ, Bedotto JB, Malloy CR, et al. Effect of β-adrenergic blockade on myocardial function and energetics in congestive heart failure. Circulation 1990; 82: 473-483.
7. Monrad E, Baim D, Smith H, Lanoue A. Milrinone, dobutamine, and nitroprusside: comparative effects on hemodynamics and myocardial energetics in patients with severe congestive heart failure. Circulation 1986; 73 (Suppl): III-168-III-174.
8. Suga H, Igarashi Y, Yamada O, Goto Y. Mechanical efficiency of the left ventricle as a function of preload, afterload and contractility. Heart Vessels 1985; 1: 3-8.
9. Wolpers HG, Buck A, Nguyen N, et al. An approach to ventricular efficiency by use of carbon 11-labeled acetate and positron emission tomography. J Nucl Cardiol 1994; 1: 262-269.
10. Buxton DB, Schwaiger M, Nguyen A, Phelps ME, Schelbert HR. Radiolabelled acetate as a tracer of myocardial tricarboxylic acid cycle flux. Circ Res 1988; 63: 628-634.
11. 11C]acetate as a tracer for noninvasive assessment of oxidative metabolism with positron emission tomography in normal, ischemic, postischemic, and hyperemic canine myocardium. Circulation 1990; 81: 1594-1605.
12. Beanlands RS, Bach DS, Raylman R, et al. Acute effects of dobutamine on myocardial oxygen consumption and cardiac efficiency measured using carbon-11 acetate kinetics in patients with dilated cardiomyopathy. J Am Coll Cardiol 1993; 22: 1389-1398.
13. Beanlands RS, Armstrong WF, Hicks R, et al. The effects of afterload reduction on C-11 acetate kinetics in patients with dilated cardiomyopathy. J Nucl Cardiol 1994; 1: 3-16.
14. 11C) acetate - an agent for the study of myocardial metabolism by positron emission tomography. Int J Appl Radiat Isot 1982; 33: 505-512.
15. Batchelor S, Blake GM, Saunders JE. A comparison of three commercially available PET imaging systems. Nucl Med Commun 1992; 13: 20-27.
16. Wienhard K, Eriksson L, Grootoonk S, Casey M, Pietrzyk U, Heiss WD. Performance evaluation of the positron scanner ECAT EXACT. J Comput Assist Tomogr 1992; 16: 804-813.
17. Baur LHB, Schipperheyn JJ, van der Velde EA, et al. Reproducibility of left ventricular size, shape and mass with echocardiography, magnetic resonance imaging and radionuclide angiography in patients with anterior wall infarction. Int J Card Imaging 1996; 12: 233-240.
18. Nekolla SG, Stollfuß J, Bachmann R, Spyra L, Neverve J, Schwaiger M. Automated assessment of LV-EF and volumes by gated blood pool SPECT: comparison to gated MRI [abstract]. J Nucl Med 1996; 37: 218P.
19. Nekolla SG, Miethaner C, Nguyen N, Ziegler SI, Schwaiger M. Reproducibility of polar map generation and assessment of defect severity and extent assessment in myocardial perfusion imaging using positron emission tomography. Eur J Nucl Med 1998; 25: 1313-1321.
20. Gropler RJ, Siegel BA, Geltman EM. Myocardial uptake of carbon-11-acetate as an indirect estimate of regional myocardial blood flow. J Nucl Med 1991; 32: 245-251.
21. Guyton AC. The relationship of cardiac output and arterial pressure control. Circulation 1981; 64: 1079-1088.
22. International Society and Federation of Cardiology/World Health Organization. Report of the task force on the definition and classification of cardiomyopathies. Br Heart J 1980; 44: 672-678.
23. Hirota Y, Shimizu G, Kaku K, Saito T, Kino M, Kawamura K. Mechanisms of compensation and decompensation in dilated cardiomyopathy. Am J Cardiol 1984; 54: 1033-1038.
24. Riegger GA, Kochsiek K. Vasopressin, renin and norepinephrine levels before and after captopril administration in patients with congestive heart failure due to idiopathic dilated cardiomyopathy. Am J Cardiol 1986; 58: 300-303.
25. Bengel FM, Ueberfuhr P, Nekolla S, Ziegler S, Reichart B, Schwaiger M. Oxidative metabolism of the transplanted human heart assessed by positron emission tomography using C-11 acetate. Am J Cardiol 1999; 83: 1503-1505.
26. Hicks RJ, Savas V, Currie PJ, et al. Assessment of myocardial oxidative metabolism in aortic valve disease using positron emission tomography with C-11 acetate. Am Heart J 1992; 123: 653-664.
27. Krivokapich J, Huang SC, Schelbert HR. Assessment of the effects of dobutamine on myocardial blood flow and oxidative metabolism in normal human subjects using nitrogen-13 ammonia and carbon-11 acetate. Am J Cardiol 1993; 71: 1351-1356.
28. 31P magnetic resonance spectroscopy in dilated cardiomyopathy and coronay artery disease. Circulation 1992; 86: 1810-1818.
29. Hajjar RJ, Gwathmey JK. Cross-bridge dynamics in human ventricular myocardium. Circulation 1992; 86: 1819-1826.
30. Margossian SS, White HD, Caulfield JB, Norton P, Taylor S, Slayter HS. Light chain 2 profile and activity of human ventricular myosin during dilated cardiomyopathy. Circulation 1992; 85: 1720-1733.
31. Ungerer M, Böhm M, Elce JS, Erdmann E, Lohse MJ. Altered expression of β-adrenergic receptor kinase (ßARK) and ß1-adrenergic receptors in the failing human heart. Circulation 1993; 78: 454-463.
32. Bohm M, La Rosee K, Schwinger RHG, Erdmann E. Evidence for reduction of norepinephrine uptake sites in the failing human heart. J Am Coll Cardiol 1995; 25: 146-153.
33. Baruch L, Anand I, Cohen IS, Ziesche S, Judd D, Cohn JN. Augmented short- and long-term hemodynamic and hormonal effects of an angiotensin receptor blocker added to angiotensin converting enzyme inhibitor therapy in patients with heart failure. Vasodilator Heart Failure Trial (V-HeFT) Study Group. Circulation 1999; 99: 2658-2664.